Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 5Not yet recruiting 3Unknown 1Terminated 1

Sponsor Class

INDUSTRY 3OTHER_GOV 1NIH 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 2Classical hematology 1

Conditions

Breast Neoplasms 6392Neoplasms 5365Prostatic Neoplasms 2966Carcinoma, Non-Small-Cell Lung 2709Colorectal Neoplasms 2679Lung Neoplasms 2267Multiple Myeloma 1663Lymphoma 1600Neoplasm Metastasis 1552Leukemia, Myeloid, Acute 1540Melanoma 1486Pancreatic Neoplasms 1470Ovarian Neoplasms 1423Leukemia 1389Head and Neck Neoplasms 1284Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1129Leukemia, Lymphocytic, Chronic, B-Cell 1090Brain Neoplasms 1050Rectal Neoplasms 980Lymphoma, Follicular 979Recurrence 976Uterine Cervical Neoplasms 926Glioblastoma 920Carcinoma, Renal Cell 882Lymphoma, Large B-Cell, Diffuse 853Hodgkin Disease 777

Interventions

copanlisib 1alisporivir 1Trabectedin 1Raltegravir Potassium 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Hepatic Insufficiency × Clear all
NCT01022476 2026-04-06

LIVERAL

ANRS, Emerging Infectious Diseases

Phase 1/2 Completed
14 enrolled
Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

NCT03172884 2021-04-28

Study of Copanlisib in Hepatic or Renal Impairment

Bayer

Phase 1 Completed
30 enrolled 20 charts

Hepatic Insufficiency, Renal Insufficiency

NCT00341705 2019-12-17

The Second Multicenter Hemophilia Cohort Study

National Institutes of Health Clinical Center (CC)

Completed
2,565 enrolled
Classical hematologyGastrointestinalLymphoid

Acquired Immunodeficiency Syndrome, Hemophilia A, Hepatitis C, Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Neoplasms, Hepatic Insufficiency

NCT01860326 2016-04-28

Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects

Debiopharm International SA

Phase 1 Completed
32 enrolled
Lymphoid

Lymphoma, Follicular, Hepatic Insufficiency

NCT01273493 2016-02-15

A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Janssen Research & Development, LLC

Phase 1 Completed
15 enrolled

Liver Diseases, Neoplasm Metastasis, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡